#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Severe Maternal Sepsis in the UK, 2011–2012: A National Case-Control Study


Background:
In light of increasing rates and severity of sepsis worldwide, this study aimed to estimate the incidence of, and describe the causative organisms, sources of infection, and risk factors for, severe maternal sepsis in the UK.

Methods and Findings:
A prospective case-control study included 365 confirmed cases of severe maternal sepsis and 757 controls from all UK obstetrician-led maternity units from June 1, 2011, to May 31, 2012. Incidence of severe sepsis was 4.7 (95% CI 4.2–5.2) per 10,000 maternities; 71 (19.5%) women developed septic shock; and five (1.4%) women died. Genital tract infection (31.0%) and the organism Escherichia coli (21.1%) were most common. Women had significantly increased adjusted odds ratios (aORs) of severe sepsis if they were black or other ethnic minority (aOR = 1.82; 95% CI 1.82–2.51), were primiparous (aOR = 1.60; 95% CI 1.17–2.20), had a pre-existing medical problem (aOR = 1.40; 95% CI 1.01–1.94), had febrile illness or were taking antibiotics in the 2 wk prior to presentation (aOR = 12.07; 95% CI 8.11–17.97), or had an operative vaginal delivery (aOR = 2.49; 95% CI 1.32–4.70), pre-labour cesarean (aOR = 3.83; 95% CI 2.24–6.56), or cesarean after labour onset (aOR = 8.06; 95% CI 4.65–13.97). Median time between delivery and sepsis was 3 d (interquartile range = 1–7 d). Multiple pregnancy (aOR = 5.75; 95% CI 1.54–21.45) and infection with group A streptococcus (aOR = 4.84; 2.17–10.78) were associated with progression to septic shock; for 16 (50%) women with a group A streptococcal infection there was <2 h—and for 24 (75%) women, <9 h—between the first sign of systemic inflammatory response syndrome and a diagnosis of severe sepsis. A limitation of this study was the proportion of women with sepsis without an identified organism or infection source (16.4%).

Conclusions:
For each maternal sepsis death, approximately 50 women have life-threatening morbidity from sepsis. Follow-up to ensure infection is eradicated is important. The rapid progression to severe sepsis highlights the importance of following the international Surviving Sepsis Campaign guideline of early administration of high-dose intravenous antibiotics within 1 h of admission to hospital for anyone with suspected sepsis. Signs of severe sepsis in peripartum women, particularly with confirmed or suspected group A streptococcal infection, should be regarded as an obstetric emergency.

Please see later in the article for the Editors' Summary


Vyšlo v časopise: Severe Maternal Sepsis in the UK, 2011–2012: A National Case-Control Study. PLoS Med 11(7): e32767. doi:10.1371/journal.pmed.1001672
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001672

Souhrn

Background:
In light of increasing rates and severity of sepsis worldwide, this study aimed to estimate the incidence of, and describe the causative organisms, sources of infection, and risk factors for, severe maternal sepsis in the UK.

Methods and Findings:
A prospective case-control study included 365 confirmed cases of severe maternal sepsis and 757 controls from all UK obstetrician-led maternity units from June 1, 2011, to May 31, 2012. Incidence of severe sepsis was 4.7 (95% CI 4.2–5.2) per 10,000 maternities; 71 (19.5%) women developed septic shock; and five (1.4%) women died. Genital tract infection (31.0%) and the organism Escherichia coli (21.1%) were most common. Women had significantly increased adjusted odds ratios (aORs) of severe sepsis if they were black or other ethnic minority (aOR = 1.82; 95% CI 1.82–2.51), were primiparous (aOR = 1.60; 95% CI 1.17–2.20), had a pre-existing medical problem (aOR = 1.40; 95% CI 1.01–1.94), had febrile illness or were taking antibiotics in the 2 wk prior to presentation (aOR = 12.07; 95% CI 8.11–17.97), or had an operative vaginal delivery (aOR = 2.49; 95% CI 1.32–4.70), pre-labour cesarean (aOR = 3.83; 95% CI 2.24–6.56), or cesarean after labour onset (aOR = 8.06; 95% CI 4.65–13.97). Median time between delivery and sepsis was 3 d (interquartile range = 1–7 d). Multiple pregnancy (aOR = 5.75; 95% CI 1.54–21.45) and infection with group A streptococcus (aOR = 4.84; 2.17–10.78) were associated with progression to septic shock; for 16 (50%) women with a group A streptococcal infection there was <2 h—and for 24 (75%) women, <9 h—between the first sign of systemic inflammatory response syndrome and a diagnosis of severe sepsis. A limitation of this study was the proportion of women with sepsis without an identified organism or infection source (16.4%).

Conclusions:
For each maternal sepsis death, approximately 50 women have life-threatening morbidity from sepsis. Follow-up to ensure infection is eradicated is important. The rapid progression to severe sepsis highlights the importance of following the international Surviving Sepsis Campaign guideline of early administration of high-dose intravenous antibiotics within 1 h of admission to hospital for anyone with suspected sepsis. Signs of severe sepsis in peripartum women, particularly with confirmed or suspected group A streptococcal infection, should be regarded as an obstetric emergency.

Please see later in the article for the Editors' Summary


Zdroje

1. WaterstoneM, BewleyS, WolfeC (2001) Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 322: 1089–1093.

2. CantwellR, Clutton-BrockT, CooperG, DawsonA, DrifeJ, et al. (2011) Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The eighth report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 118 (Suppl 1) 1–203 doi:10.1111/j.1471-0528.2010.02847.x

3. SchutteJM, SteegersEAP, SchuitemakerNWE, SantemaJG, de BoerK, et al. (2010) Rise in maternal mortality in the Netherlands. BJOG 117: 399–406 doi:10.1111/j.1471-0528.2009.02382.x

4. AcostaCD, KnightM, LeeHC, KurinczukJJ, GouldJB, et al. (2013) The continuum of maternal sepsis severity: incidence and risk factors in a population-based cohort study. PLoS ONE 8: e67175 doi:10.1371/journal.pone.0067175

5. KhanKS, WojdylaD, SayL, GülmezogluAM, Van LookPFA (2006) WHO analysis of causes of maternal death: a systematic review. Lancet 367: 1066–1074 doi:10.1016/S0140-6736(06)68397-9

6. AcostaCD, KnightM (2013) Sepsis and maternal mortality. Curr Opin Obstet Gynecol 25: 109–116 doi:10.1097/GCO.0b013e32835e0e82

7. SchuitemakerN, van RoosmalenJ, DekkerG, van DongenP, van GeijnH, et al. (1998) Increased maternal mortality in The Netherlands from group A streptococcal infections. Eur J Obstet Gynecol Reprod Biol 76: 61–64.

8. KnightM, KurinczukJJ, TuffnellD, BrocklehurstP (2005) The UK Obstetric Surveillance System for rare disorders of pregnancy. BJOG 112: 263–265 doi:10.1111/j.1471-0528.2005.00609.x

9. BoneRC, BalkRA, CerraFB, DellingerRP, FeinAM, et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644–1655.

10. Department of Health (2000) Comprehensive critical care. London: Department of Health.

11. Office for National Statistics (2013) Live births in England and Wales by characteristics of mother 1, 2011. Available: http://www.ons.gov.uk/ons/rel/vsob1/characteristics-of-Mother-1—england-and-wales/2011/sb-characteristics-of-mother-1.html. Accessed 10 June 2014.

12. Northern Ireland Statistics and Research Agency (2012) Live births 1887 to 2012. Available: http://www.nisra.gov.uk/demography/default.asp8.htm. Accessed 16 August 2012.

13. General Register Office for Scotland (2013) Vital events reference tables 2011. Available: http://www.gro-scotland.gov.uk/statistics/theme/vital-events/general/ref-tables/2011/section-3-births.html. Accessed 19 February 2013.

14. ParukF (2008) Infection in obstetric critical care. Best Pract Res Clin Obstet Gynaecol 22: 865–883 doi:10.1016/j.bpobgyn.2008.06.011

15. KinasewitzGT, YanSB, BassonB, CompP, RussellJA, et al. (2004) Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism. Crit Care 8: R82–R90 doi:10.1186/cc2459

16. LindquistA, KnightM, KurinczukJJ (2013) Variation in severe maternal morbidity according to socioeconomic position: a UK national case-control study. BMJ Open 3: e002742 doi:10.1136/bmjopen-2013-002742

17. BlandJM, AltmanDG (1994) Matching. BMJ 309: 1128.

18. MaharajD (2007) Puerperal pyrexia: a review. Part I. Obstet Gynecol Surv 62: 393–399 doi:10.1097/01.ogx.0000265998.40912.5e

19. AcostaCD, BhattacharyaS, TuffnellD, KurinczukJJ, KnightM (2012) Maternal sepsis: a Scottish population-based case-control study. BJOG 119: 474–483 doi:10.1111/j.1471-0528.2011.03239.x

20. KramerHMC, SchutteJM, ZwartJJ, SchuitemakerNWE, SteegersEAP, et al. (2009) Maternal mortality and severe morbidity from sepsis in the Netherlands. Acta Obstet Gynecol Scand 88: 647–653 doi:10.1080/00016340902926734

21. BauerME, BatemanBT, BauerST, ShanksAM, MhyreJM (2013) Maternal sepsis mortality and morbidity during hospitalization for delivery: temporal trends and independent associations for severe sepsis. Anesth Analg 117: 944–950 doi:10.1213/ANE.0b013e3182a009c3

22. SriskandanS (2011) Severe peripartum sepsis. J R Coll Physicians Edinb 41: 339–346 doi:10.4997/JRCPE.2011.411

23. AppelboamR, TilleyR, BlackburnJ (2010) Time to antibiotics in sepsis. Crit Care 14: 1–1 doi:10.1186/cc8282

24. SeniorK (2012) In the dark about sepsis. Lancet Infect Dis 12: 751–752 doi:10.1016/S1473-3099(12)70233-5

25. DellingerRP, LevyMM, RhodesA, AnnaneD, GerlachH, et al. (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39: 165–228 doi:10.1007/s00134-012-2769-8

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2014 Číslo 7
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#